Swiss National Bank - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$477,000
+4.4%
404,3790.0%0.00%
Q2 2022$457,000
-62.2%
404,3790.0%0.00%
-100.0%
Q1 2022$1,209,000
+22.5%
404,379
+8.6%
0.00%0.0%
Q4 2021$987,000
-27.0%
372,4790.0%0.00%0.0%
Q3 2021$1,352,000
-16.4%
372,4790.0%0.00%0.0%
Q2 2021$1,617,000
+23.5%
372,479
-2.7%
0.00%0.0%
Q1 2021$1,309,000
-2.2%
382,6790.0%0.00%0.0%
Q4 2020$1,339,000
+45.9%
382,6790.0%0.00%0.0%
Q3 2020$918,000
+31.1%
382,6790.0%0.00%0.0%
Q2 2020$700,000
+40.0%
382,679
+19.3%
0.00%0.0%
Q1 2020$500,000
-27.1%
320,7790.0%0.00%0.0%
Q4 2019$686,000
+18.3%
320,779
+3.5%
0.00%0.0%
Q3 2019$580,000
-28.3%
310,0790.0%0.00%0.0%
Q2 2019$809,000
+12.5%
310,079
+10.9%
0.00%0.0%
Q1 2019$719,000
+11.8%
279,5790.0%0.00%0.0%
Q4 2018$643,000
-26.1%
279,579
+3.1%
0.00%0.0%
Q3 2018$870,000
+13.4%
271,1790.0%0.00%0.0%
Q2 2018$767,000
-5.7%
271,179
+18.1%
0.00%0.0%
Q1 2018$813,000
-8.8%
229,6000.0%0.00%0.0%
Q4 2017$891,000
+400.6%
229,600
+150.7%
0.00%0.0%
Q3 2014$178,000
-46.5%
91,6000.0%0.00%0.0%
Q2 2014$333,000
-16.3%
91,600
-10.6%
0.00%
-50.0%
Q1 2014$398,000
+85.1%
102,500
+35.8%
0.00%
+100.0%
Q4 2013$215,000
-20.4%
75,5000.0%0.00%0.0%
Q3 2013$270,000
-2.2%
75,500
-8.5%
0.00%0.0%
Q2 2013$276,00082,5000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders